Introduction
• Hyperglycemia is common in critically ill patients and is associated with increased morbidity and mortality
• Intensive Insulin Therapy (IIT) has been widely adopted
• Concerns persist over rates of hypoglycemia in patients on IIT
• There is emerging evidence that blood glucose variability is a better predictor of adverse outcomes
Summary of IIT Literature
Meta-analysis of IIT in critical illness
• All studies combined:
-no significant benefit
• Surgical ICU studies: -significant benefit 
Conclusions
• Patients who experience hypoglycemia are characterized by higher BG variability prior to the event
• BG variability increases in the 8 hours preceding a hypoglycemic event
• Patients with high BG variability are at increased risk for hypoglycemia during the period their BG variability remains high
• Prospective measuring of BG variability may provide means for early identification of patients at high risk for hypoglycemia, and provide an opportunity to mitigate this risk
